Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer

Stathmin is a prognostic marker in many cancers, including endometrial cancer. Preclinical studies, predominantly in breast cancer, have suggested that stathmin may additionally be a predictive marker for response to paclitaxel. We first evaluated the response to paclitaxel in endometrial cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Henrica M. J., Trovik, Jone, Halle, Mari K., Wik, Elisabeth, Akslen, Lars A., Birkeland, Even, Bredholt, Therese, Tangen, Ingvild L., Krakstad, Camilla, Salvesen, Helga B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934991/
https://www.ncbi.nlm.nih.gov/pubmed/24587245
http://dx.doi.org/10.1371/journal.pone.0090141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934991/
https://www.ncbi.nlm.nih.gov/pubmed/24587245
http://dx.doi.org/10.1371/journal.pone.0090141

Ejemplares similares